Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Operating Officer gave up 1,395 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 4,678 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Operating Officer gave up 4,671 shares (to pay taxes)
  16. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 36,441 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 11,023 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Operating Officer gave up 10,553 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 10,553 shares (to pay taxes)
  20. 4 Open-market buy Director bought 10,000 shares at $6.15 ($61,500)

Page 8 of 18 · 352 filings